Table 5.

Psoriasis patients; stated importance of attributes

	Stated importance of treatment attributes Mean score (standard deviation) (1 = not at all critical; 9 = extremely critical)
	Moderate psoriasis	Severe psoriasis
Efficacy
Reduction in symptoms associated with lesions	8.2 (1.4)	8.1 (1.3)
Reduction in redness, thickness, and scale	8.0 (1.4)	8.1 (1.2)
Maintenance of response over time	8.0 (1.3)	8.1 (1.3)
Improvement in QoL	8.0 (1.3)	7.9 (1.6)
% reduction in BSA affected	7.8 (1.4)	8.0 (1.4)
Rapidity of response after initiating treatment	7.7 (1.4)	7.8 (1.4)
Scientific or clinical information presented by a doctor that demonstrates efficacy	7.2 (1.8)	7.3 (1.8)
Scientific or clinical information about efficacy from sources other than a doctor	6.9 (1.7)	7.0 (2.0)
Safety
Low potential for serious adverse events	8.1 (1.5)	8.1 (1.2)
Low potential for minor side effects	7.6 (1.8)	7.6 (1.5)
Other
Therapy is affordable/has reasonable out-of-pocket costs	8.0 (1.4)	8.0 (1.4)
How often you need to receive a medication	6.9 (2.1)	7.0 (2.0)
How the medication is taken (e.g., orally as a pill or tablet, subcutaneous injection, infusion)	6.6 (2.5)	6.8 (2.4)